Michael Klayko, Director at ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. (MDRX), bought 5,000 shares at $11.26 ($56K) on 2014-11-11, disclosed to the SEC on 2014-11-12.
Open-market purchase of $56k MDRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| CONE | SELL | 2020-05-08 | $812K | — | Filing → |
| CONE | BUY | 2019-03-11 | $200K | — | Filing → |
| MDRX | BUY | 2018-06-14 | $50K | — | Filing → |